Intellect Neurosciences neurology news

Intellect retained Evli Corporate Finance as financial adviser to review the company's strategic and financial alternatives, which may include partnerships, strategic business model alternatives, a sale or other transactions. Intellect said it chose Evli for the review because "several" of the company's potential partners are based in Europe. At March 31, the company had $85,828 in cash and a nine-month operating loss of $4 million. ...